Study Suggests Food Can Suppress Main Dengue Fever-Like Symptoms


Clinical trial confirms Kirin Holdings’ Lactococcus lactis strain Plasma effective against the cureless and vaccineless virus

TOKYO, JAPAN –  (KV 2027), a long-term management plan launched in 2019, the Kirin Group aims to become “A global leader in CSV*, creating value across our world of Food & Beverages to Pharmaceuticals.” Going forward, the Kirin Group will continue to leverage its strengths to create both social and economic value through its businesses, with the aim of achieving sustainable growth in corporate value.

* Creating Shared Value: combined added value for consumers as well as for society at large.